Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Aarti Industries advances on commencing commercial production at Ethylation unit

06-Sep2016

Aarti Industries advances on commencing commercial production at Ethylation unit

Aarti Industries is currently trading at Rs. 623.80, up by 7.80 points or 1.27% from its previous closing of Rs. 616.00 on the BSE.

The scrip opened at Rs. 625.00 and has touched a high and low of Rs. 630.00 and Rs. 623.80 respectively. So far 1,939 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 635.40 on 30-Aug-2016 and a 52 week low of Rs. 388.35 on 08-Sep-2015.

Last one week high and low of the scrip stood at Rs. 635.40 and Rs. 599.00 respectively. The current market cap of the company is Rs. 5,197.00 crore.

The promoters holding in the company stood at 54.80%, while Institutions and Non-Institutions held 15.47% and 29.72% respectively.

Aarti Industries, a leading global Speciality Chemicals company with significant presence in Pharmaceuticals has commenced the commercial production at its multipurpose Ethylation unit at Dahej SEZ, Gujarat and the 2nd Phase of PDA expansion with effect from September 2, 2016.

The Greenfield Ethylation unit has adopted Swiss Technology and has the capacity to manufacture about 8,000 to10,000 tpa of Ethylene derivatives. The initial product manufactured at this unit has applications into Herbicides (Agrochemicals) and the company plans to add other products in due course with applications majorly into Agrochemicals, catering to global Agrochemical majors. Additionally, the company has started the commercial production of its 2nd Phase of PDA expansion from 450 tpm to 1,000 tpm. The products are used in high growth industries mainly. These units shall facilitate the company to further strengthen its global presence in the end-user applications of Polymers and Agrochemicals.

Aarti Industries is the leading and highly integrated chemical manufacturer involved in mainly manufacturing various benzene based downstream and derivative products.



Related News

View all news

IndiGo trades in green on the BSE

Interglobe Aviation (IndiGo) is currently trading at Rs. 1063.55, up by 20.35 points or 1.95% from its previous closing of Rs. 1043.20 on the BSE.The scrip opened at Rs. 1034.00 and has touched a high......

Shilpa Medicare surges on getting tentative ANDA approval for Dimethyl Fumarate DR Capsules

Shilpa Medicare is currently trading at Rs. 388.65, up by 14.65 points or 3.92% from its previous closing of Rs. 374.00 on the BSE.The scrip opened at Rs. 383.95 and has touched a high and low of Rs. 399.75......

Pfizer shines despite reporting 14% fall in Q2 net profit

Pfizer is currently trading at Rs. 2865.00, up by 86.25 points or 3.10% from its previous closing of Rs. 2778.75 on the BSE.The scrip opened at Rs. 2815.50 and has touched a high and low of Rs. 2866.80......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......